Patents Assigned to PH Therapeutics
  • PULMONARY HYPERTENSION
    Publication number: 20150010562
    Abstract: The disclosure relates to agents that inhibit the activity of Tumour Necrosis Factor Apoptosis-Inducing Ligand [TRAIL] and their use in the treatment of pulmonary hypertension.
    Type: Application
    Filed: October 23, 2012
    Publication date: January 8, 2015
    Applicant: PH Therapeutics
    Inventor: Allan Lawrie
  • PULMONARY HYPERTENSION
    Publication number: 20140255404
    Abstract: The disclosure relates to agents that inhibit the activity of osteoprotegerin and their use in the treatment of pulmonary hypertension.
    Type: Application
    Filed: October 23, 2012
    Publication date: September 11, 2014
    Applicant: PH Therapeutics
    Inventor: Allan Lawrie